The patient was clinically diagnosed with liver cirrhosis and splenomegaly before medication. Several years after the diagnosis of liver cirrhosis, the patient accepted a variety of therapies and adjusted diet. The patient’s liver stiffness indicators showed a trend of gradual improvement year by year, but the stiffness value was still higher. After one month of administration of CHA for injection alone, the liver stiffness indicators were reduced (from 8.5 to 7.7), and spleen enlargement not resolved was also alleviated, and the spleen thickness decreased (from 7.0 cm to 5.7 cm). The patient continued to take the drug so far, with the quality of life greatly improved, better self-perceived energy, sleep and appetite improvement, and basically disappeared swelling of fingers.